Anti-Thymoglobulin, Rabbit
Fucosidosis
Masonic Cancer Center, University of MinnesotaPhase 2/3Active
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Fucosidosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Masonic Cancer Center, University of Minnesota | Phase 2/3 | BB |
Busulphan Masonic Cancer Center, University of Minnesota | Phase 2/3 | BB |
CYCLOSPORIN A Masonic Cancer Center, University of Minnesota | Phase 2 | BB |
Cald Hr-D Masonic Cancer Center, University of Minnesota | Phase 2 | CCC |
Campath-1H Masonic Cancer Center, University of Minnesota | Phase 2 | CCC |
Human Placental Derived Stem Cell New York Medical College | Phase 1 | CC |
Same molecule, other indications
Anti-Thymoglobulin, Rabbit is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →